The Johnson & Johnson research and product pipeline is driven by discovering and developing transformational healthcare solutions and the company’s global public health strategy to make innovative medicines and technologies accessible in the world’s most vulnerable communities and resource-poor settings. Fueling innovation and finding the best science, wherever it exists, is the driving force behind the launch of Johnson & Johnson Innovation in 2013, to foster science and technology through strategic partnerships, licensing and acquisitions. The space age will demand novel approaches to the development and delivery of pharmaceutical products, medical devices and products from applied research in life science, a core domain of the company.<br/>

Johnson & Johnson: Innovative medicines & technologies

2019 Spring National Meeting

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.